IBDXvsUJB
iShares iBonds Dec 2032 Term Corporate ETF against ProShares Ultra High Yield — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBDX | UJB | |
|---|---|---|
| Expense ratio | 0.10% | 0.96% |
| Assets | $1.7B | $5901.50T |
| Net flow, 1 month | +$24M | −$4M |
| Net flow, 1 year | +$551M | +$2M |
| Return, YTD | -6.1% | -6.7% |
| Return, 1 year | -6.3% | -5.8% |
| Avg daily volume | 389K | 14K |
| Holdings | 318 | 5 |
| Listed | Jun 28, 2022 | Apr 14, 2011 |
| Options market | No | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS